EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway

Yashu Wang, Xinna Deng, Jinying Wei, Zhaohua Yang, Yunxia Du, Shan Song, Yonghong Shi, Haijiang Wu iD

PLOS ONE · 13.06.2024 · 19 (6) · e0299389

DOI: 10.1371/journal.pone.0299389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.06.2024. Verfasst von Yashu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Ureteral Obstruction, Fibrosis, Fibronectins, Matrix Metalloproteinase 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Hebei Science and Technology Department Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis is the most common pathway in progressive kidney diseases. The unilateral ureteral obstruction (UUO) model is used to induce progressive renal fibrosis. We evaluated the effects of irisin on renal interstitial fibrosis in UUO mice. The GSE121190, GSE36496, GSE42303, and GSE96101 datasets were downloaded from the Gene Expression Omnibus (GEO) database. In total, 656 differentially expressed genes (DEGs) were identified in normal and UUO mouse renal samples. Periostin and matrix metalloproteinase-2 (MMP-2) were selected to evaluate the effect of irisin on renal fibrosis in UUO mice. In UUO mice, irisin ameliorated renal function, decreased the expression of periostin and MMP-2, and attenuated epithelial-mesenchymal transition and extracellular matrix deposition in renal tissues. In HK-2 cells, irisin treatment markedly attenuated TGF-β1-induced expression of periostin and MMP-2. Irisin treatment also inhibited TGF-β1-induced epithelial-mesenchymal transition, extracellular matrix formation, and inflammatory responses. These protective effects of irisin were abolished by the overexpression of periostin and MMP-2. In summary, irisin treatment can improve UUO-induced renal interstitial fibrosis through the TGF-β1/periostin/MMP-2 signaling pathway, suggesting that irisin may be used for the treatment of renal interstitial fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ureteral ObstructionFibrosisFibronectinsMatrix Metalloproteinase 2Signal TransductionTransforming Growth Factor beta1Cell Adhesion MoleculesEpithelial-Mesenchymal TransitionKidney DiseasesAnimalsMiceMaleHumansKidneyMice, Inbred C57BLCell LineDisease Models, AnimalPeriostin

Substanzen

FibronectinsMatrix Metalloproteinase 2Transforming Growth Factor beta1Cell Adhesion MoleculesPostn protein, mouseFNDC5 protein, mousePeriostin

Autor:innen und Institutionen

  • Department of Pathology, Hebei Medical University, Shijiazhuang, China.
  • Department of Oncology, Hebei General Hospital, Shijiazhuang, China.

ORCID-Profile: Haijiang Wu

Förderung

  • This work was supported by the Hebei Science and Technology Department Program

Zitieren

APA

Wang, Y., Deng, X., Wei, J., Yang, Z., Du, Y., Song, S., Shi, Y., & Wu, H. (2024). Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLOS ONE, 19(6), e0299389. https://doi.org/10.1371/journal.pone.0299389

Vancouver

Wang Y, Deng X, Wei J, Yang Z, Du Y, Song S, et al. Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLOS ONE. 2024;19(6):e0299389. doi:10.1371/journal.pone.0299389

BibTeX
@article{Wang2024,
  author = {Wang, Yashu and Deng, Xinna and Wei, Jinying and Yang, Zhaohua and Du, Yunxia and Song, Shan and Shi, Yonghong and Wu, Haijiang},
  title = {Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0299389},
  doi = {10.1371/journal.pone.0299389}
}
Kostenlos starten →